Stay updated on APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Sign up to get notified when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page

  1. Check
    6 days ago
    No Change Detected
  2. Check
    13 days ago
    Change Detected
    Summary
    Revision: v3.4.2 was added, and notices about government funding lapse and operating status were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-12T02:09:56.000Z thumbnail image
  3. Check
    20 days ago
    Change Detected
    Summary
    A government funding notice banner is displayed on the page, informing visitors of potential delays and status updates. The revision tag has been updated from v3.4.0 to v3.4.1.
    Difference
    0.4%
    Check dated 2026-02-04T12:45:24.000Z thumbnail image
  4. Check
    28 days ago
    Change Detected
    Summary
    Added a glossary display and a new 'Last Update Submitted that Met QC Criteria' field. The footer now shows 'No FEAR Act Data' and a 'Revision: v3.4.0' indicator.
    Difference
    0.2%
    Check dated 2026-01-28T11:13:33.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    Revision updated from v3.3.3 to v3.3.4. This appears to be a metadata update with no impact on study details or content.
    Difference
    0.0%
    Check dated 2026-01-14T03:24:20.000Z thumbnail image
  6. Check
    63 days ago
    Change Detected
    Summary
    Locations section updated to add a consolidated list of study sites across California, Colorado, District of Columbia, Florida, Georgia, Indiana, Louisiana, Maryland, Missouri, New York, North Carolina, Tennessee, Virginia, and Wisconsin. A new Revision: v3.3.3 appears and older state-specific locations and the HHS Vulnerability Disclosure link were removed (Revision: v3.3.2).
    Difference
    1%
    Check dated 2025-12-23T21:40:35.000Z thumbnail image
  7. Check
    92 days ago
    Change Detected
    Summary
    Added a notice that publications are automatically filled from PubMed and that the revision is v3.3.2. Removed the previous notice describing PubMed-sourced publications and the older revision v3.2.0.
    Difference
    0.1%
    Check dated 2025-11-25T10:36:10.000Z thumbnail image

Stay in the know with updates to APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial

Enter your email address, and we'll notify you when there's something new on the APL-2 Safety & Efficacy in Glomerulopathies Clinical Trial page.